A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells-Reference-Cited by-同舟云学术

A B-cell lymphoma vaccine using a depot formulation of interleukin-2 induces potent antitumor immunity despite increased numbers of intratumoral regulatory T cells

Published:2009-09-19 Issue:4 Volume:59 Page:519-527
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Grille Sofía,Brugnini Andreína,Nese Martha,Corley Esteban,Falkenberg Frank W.,Lens Daniela,Chabalgoity José A.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-009-0768-6.pdf

Reference42 articles.

1. Marcus R, Hagenbeek A (2007) The therapeutic use of rituximab in non-Hodgkin’s lymphoma. Eur J Haematol Suppl (67):5–14

2. Neelapu SS, Kwak LW (2007) Vaccine therapy for B-cell lymphomas: next-generation strategies. In: Gewirtz AM, Winter JN, Zuckerman K (eds) American Society of Hematology education program book. Atlanta, GA, pp 243–249

3. Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW (2006) Therapeutic lymphoma vaccines: importance of T-cell immunity. Expert Rev Vaccines 5(3):381–394

4. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R (1992) Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327(17):1209–1215

5. Hsu FJ, Caspar CB, Czerwinski D, Kwak LW, Liles TM, Syrengelas A, Taidi-Laskowski B, Levy R (1997) Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma—long-term results of a clinical trial. Blood 89(9):3129–3135

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leishmania braziliensis enhances monocyte responses to promote anti-tumor activity;Cell Reports;2024-03

2. Immunopathology and Immunotherapy of Non-Hodgkin Lymphoma;Cancer Immunology;2020

3. Immunopathology and Immunotherapy of Hodgkin Lymphoma;Cancer Immunology;2020

4. Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice;Frontiers in Immunology;2018-01-23

5. A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenario;Journal of Translational Medicine;2016-11-22